Omzo vs Try Ageless: Compare pricing, formats, and clinician model
Quick verdict: Omzo emphasizes clinician-guided, personalized compounded semaglutide care starting at $179 and also connects patients with prescriptions for branded GLP-1s; Try Ageless focuses on format choice and lower prepaid monthly pricing, offering semaglutide, tirzepatide injections and needle-free tirzepatide oral drops from $159/mo.
Start Omzo clinician-guided care
How Omzo vs Try Ageless differ at a glance
This comparison of Omzo vs Try Ageless focuses on five supported differences: starting price structure, medication formats and switching, compounded versus branded prescription options, bundled services and discounts, and regulatory notices about compounding. Both vendors work with licensed U.S. clinicians and offer compounded GLP-1s; the table below summarizes key criteria.
| Criteria | Omzo | Try Ageless |
|---|---|---|
| Starting price | Semaglutide starting at $179; tirzepatide starting at $279 | From $159/mo (oral drops); semaglutide from $199/mo yearly; tirzepatide from $249/mo yearly |
| Medication formats | Compounded semaglutide and tirzepatide injections | Semaglutide injection, tirzepatide injection, and needle-free tirzepatide oral drops |
| Clinician and plan model | Clinician-guided plans reviewed by licensed U.S. providers; providers determine eligibility and prescriptions | Licensed U.S. clinicians prescribe; allows format switching under one plan with no new consult fee |
| Pricing structure and discounts | Starting fees listed; medication costs included in fees collected by Omzo | Discount built into every plan; code SLIM50 stacks extra $50 off; lowest prices require prepaid yearly plan |
| Regulatory note | Compounded medications are not FDA-approved and have not been reviewed by FDA for safety, effectiveness, or quality | Compounded medications are not FDA-approved; oral tirzepatide drops are an off-label compounded format |
Pricing and plan structure compared
Omzo advertises semaglutide starting at $179 and tirzepatide starting at $279, with medication costs included in the fees Omzo collects and pays to partner pharmacies. Try Ageless lists monthly pricing on prepaid yearly plans: drops from $159/mo, semaglutide from $199/mo, and tirzepatide from $249/mo, noting the lowest entry prices require the prepaid yearly plan. Try Ageless also states a discount is already applied to every plan and a stackable code SLIM50 is available.
Compare Try Ageless monthly plans
Medication formats and switching
Format is a major distinction in Omzo vs Try Ageless. Omzo highlights clinician-guided access to compounded semaglutide and tirzepatide, primarily as weekly injections, and also notes providers may write prescriptions for branded medications that the patient must fill separately. Try Ageless sells three formats including a needle-free tirzepatide oral drop option and allows clinicians to switch molecules or formats under the same plan with no new consult fee.
Explore Omzo medication options
Compounding, regulatory notices, and branded prescriptions
Both providers offer compounded GLP-1 products and include regulatory disclaimers. Omzo explicitly explains its Compounded Medication Program uses state-licensed sterile compounding pharmacies and states these compounded drugs are not FDA-approved. Try Ageless likewise states its compounded semaglutide and tirzepatide are prepared by state-licensed pharmacies and that compounded medications are not FDA-approved. Additionally, Try Ageless calls out that oral tirzepatide drops are an off-label compounded format because tirzepatide is not FDA-approved in oral form. Omzo also notes that providers may alternatively write prescriptions for branded FDA-approved medications which Omzo does not sell or dispense.
Bundled services and convenience features
Try Ageless advertises several bundled conveniences: B12 included in every plan, free discreet shipping, format switching without extra consult fees, cancel-anytime terms on prepaid plans, and LegitScript certification with HIPAA-compliant pharmacies. Omzo emphasizes clinician-guided plans reviewed by licensed U.S. providers and fast, discreet delivery with FSA and HSA eligibility mentioned, while placing responsibility for filling branded prescriptions on the patient when providers prescribe branded drugs.
Safety and expectations
Both sites include the qualified statement that compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, efficacy, or quality. Omzo repeats that results vary and are not guaranteed and that Omzo is not a medical practice; clinical services are provided by third party networks of U.S.-licensed clinicians who determine eligibility subject to clinician review. Try Ageless notes that the injection has more clinical trial data and generally produces greater average weight loss, and that oral drops are an off-label compounded formulation.
Conclusion: Omzo vs Try Ageless
Use the primary differences to decide: Try Ageless is best for format choice, lower prepaid monthly pricing, an included B12, and an explicit built-in discount with a stackable code. Omzo is best for patients who prioritize clinician-guided, personalized plans with the option that a provider may prescribe branded medications that you fill elsewhere, and for those who note the stated starting prices of $179 for semaglutide and $279 for tirzepatide.
See Try Ageless format and pricing details
Get started with Omzo clinician-guided care
Choose Try Ageless if you want the lowest advertised entry price on a prepaid yearly plan, needle-free tirzepatide drops, B12 bundled into plans, and a built-in discount plus a stackable code. Choose Omzo if you want clinician-guided personalized compounded semaglutide starting at $179, the option that a provider may write a prescription for branded FDA-approved GLP-1s you fill separately, and plans reviewed by licensed U.S. providers. This comparison uses only the supplied facts and qualifiers for Omzo vs Try Ageless.